|
|
Volumn 2, Issue 1, 2000, Pages 69-80
|
|
Insulin-like growth factor-I in diabetes mellitus: Its physiology, metabolic effects, and potential clinical utility
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GROWTH HORMONE;
INSULIN;
RECOMBINANT SOMATOMEDIN C;
SOMATOMEDIN BINDING PROTEIN 1;
SOMATOMEDIN BINDING PROTEIN 3;
SOMATOMEDIN C;
CLINICAL TRIAL;
DIABETES MELLITUS;
DIABETIC RETINOPATHY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SCREENING;
HUMAN;
INSULIN DEFICIENCY;
INSULIN RESISTANCE;
METABOLISM;
NONHUMAN;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
REVIEW;
DIABETES MELLITUS;
DIABETIC NEPHROPATHIES;
DIABETIC NEUROPATHIES;
DIABETIC RETINOPATHY;
HOMEOSTASIS;
HUMANS;
INSULIN RESISTANCE;
INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS;
INSULIN-LIKE GROWTH FACTOR I;
ISLETS OF LANGERHANS;
|
|
EID: 0034066670
PISSN: 15209156
EISSN: None
Source Type: Journal
DOI: 10.1089/152091599316775 Document Type: Review |
|
Times cited : (83)
|
|
References (93)
|
